These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2488698)

  • 1. Quantification and topographical description of Ki-67 antibody labelling during the cell cycle of normal fibroblastic (MRC-5) and mammary tumour cell lines (MCF-7).
    Guillaud P; du Manoir S; Seigneurin D
    Anal Cell Pathol; 1989 Feb; 1(1):25-39. PubMed ID: 2488698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactive computer-assisted analysis of chromosome 1 colocalization with nucleoli.
    Léger I; Guillaud M; Krief B; Brugal G
    Cytometry; 1994 Aug; 16(4):313-23. PubMed ID: 7988293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ki-67 labeling in postmitotic cells defines different Ki-67 pathways within the 2c compartment.
    du Manoir S; Guillaud P; Camus E; Seigneurin D; Brugal G
    Cytometry; 1991; 12(5):455-63. PubMed ID: 1935459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative flow cytometric analysis of Ki-67 and proliferating cell nuclear antigen (PCNA) in solid neoplasms.
    Steck K; el-Naggar AK
    Cytometry; 1994 Nov; 17(3):258-65. PubMed ID: 7851161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of immunohistochemical staining of proliferating cells in paraffin sections of breast carcinoma using antibodies to proliferating cell nuclear antigen and the Ki-67 antigen.
    Yu CC; Dublin EA; Camplejohn RS; Levison DA
    Anal Cell Pathol; 1995 Jul; 9(1):45-52. PubMed ID: 7577754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of nucleolar protein p120 in human lung cancer: difference in histological types as a marker for proliferation.
    Uchiyama B; Saijo Y; Kumano N; Abe T; Fujimura S; Ohkuda K; Handa M; Satoh K; Nukiwa T
    Clin Cancer Res; 1997 Oct; 3(10):1873-7. PubMed ID: 9815576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear distribution of the Ki-67 antigen during the cell cycle: comparison with growth fraction in human breast cancer cells.
    van Dierendonck JH; Keijzer R; van de Velde CJ; Cornelisse CJ
    Cancer Res; 1989 Jun; 49(11):2999-3006. PubMed ID: 2720660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A technique for automatic/interactive assessment of the proliferating fraction of neoplastic cells in solid tumors. A methodological study on the Ki-67 immunoreactive cells in human mammary carcinomas, including a comparison with the results of conventional S-phase fraction assessments by means of DNA cytometry.
    Parrado C; Falkmer UG; Höög A; Falkmer S; Ahrens O; Rius F; Grimelius L
    Gen Diagn Pathol; 1996 Mar; 141(3-4):215-27. PubMed ID: 8705786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunocytochemistry and image cytometry of progesterone receptors in breast carcinoma imprints. Expression of tissular and cellular heterogeneity: relations to biochemical assay, clinical and histological parameters and DNA analysis.
    Seigneurin D; Cohen O; Louis J
    Anal Cell Pathol; 1989 Apr; 1(2):97-104. PubMed ID: 2484853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunohistochemical marker Ki-S2: cell cycle kinetics and tissue distribution of a novel proliferation-specific antigen.
    Rudolph P; Knüchel R; Endl E; Heidebrecht HJ; Hofstäder F; Parwaresch R
    Mod Pathol; 1998 May; 11(5):450-6. PubMed ID: 9619598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of claspin as a proliferation marker in human cancer and normal tissues.
    Tsimaratou K; Kletsas D; Kastrinakis NG; Tsantoulis PK; Evangelou K; Sideridou M; Liontos M; Poulias I; Venere M; Salmas M; Kittas C; Halazonetis TD; Gorgoulis VG
    J Pathol; 2007 Feb; 211(3):331-9. PubMed ID: 17152083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescence image analysis of the MCF-7 cycle related changes in chromatin texture. Differences between AT- and GC-rich chromatin.
    Santisteban MS; Brugal G
    Anal Cell Pathol; 1995 Jul; 9(1):13-28. PubMed ID: 7577751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ki-67 antigen, a cell cycle and tumor growth marker].
    Seigneurin D; Guillaud P
    Pathol Biol (Paris); 1991 Dec; 39(10):1020-8. PubMed ID: 1666669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ki-67 and other proliferation markers useful for immunohistological diagnostic and prognostic evaluations in human malignancies.
    Gerdes J
    Semin Cancer Biol; 1990 Jun; 1(3):199-206. PubMed ID: 2103495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of staurosporine on MOLT-4 cell progression through G2 and on cytokinesis.
    Traganos F; Gong J; Ardelt B; Darzynkiewicz Z
    J Cell Physiol; 1994 Mar; 158(3):535-44. PubMed ID: 8126077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of proliferating cells in acute leukemia with antibodies to proliferating cell nuclear antigen and Ki-67 monoclonal antibodies.
    Inoue T; Yamane T; Park K; Im T; Tatsumi N; Okuda K
    Arch Pathol Lab Med; 1993 Oct; 117(10):969-72. PubMed ID: 8105766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometric evaluation of Ki67 proliferative antigen in primary breast cancer.
    Niezabitowski A; Lackowska B; Ryś J; Gruchała A; Szklarski W; Stelmach A; Wasilewska A; Kruczak A; Swiatkiewicz I
    Pol J Pathol; 1995; 46(1):17-22. PubMed ID: 7780692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell proliferation-associated nuclear antigen defined by antibody Ki-67: a new kind of cell cycle-maintaining proteins.
    Duchrow M; Schlüter C; Key G; Kubbutat MH; Wohlenberg C; Flad HD; Gerdes J
    Arch Immunol Ther Exp (Warsz); 1995; 43(2):117-21. PubMed ID: 8744726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of AgNOR and Ki-67 antigen as cell kinetic parameters in oral dysplasias and carcinomas.
    Zoeller J; Flentje M; Sinn P; Born IA
    Anal Cell Pathol; 1994 Jul; 7(1):77-88. PubMed ID: 7981138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In situ determination of the Ki-67 growth fraction (Ki-67 GF) in human tumors (studies in breast cancer)].
    Lellé RJ
    Acta Histochem Suppl; 1990; 39():109-24. PubMed ID: 2080254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.